ITGAX and asthma: In a murine model of mixed granulocytic asthma, reduced HDAC2 expression on CD11c+DCs in the lung correlates with glucocorticoid resistance during treatment, and pharmacologic restoration of HDAC2 expression on CD11c+DCs reestablishes glucocorticoid sensitivity in a mouse model of asthma (70).